Updated:
Montreux Growth Partners
Founded in 1993, Montreux Equity Partners is a private investment firm focused on making growth capital investments in the leading companies of tomorrow.
Montreux Growth Partners
Founded in 1993, Montreux Equity Partners is a private investment firm focused on making growth capital investments in the leading companies of tomorrow. Our portfolio companies address the most compelling domestic and global trends in health. We are currently investing out of our fifth fund. We focus on commercial stage companies that possess highly differentiated products, technologies, and services. At the time of investment, a company will typically have $5 to $50 million in revenues. We typically invest $10 to $20 million per company, and our capital fuels product expansion, new market entry, and strategic acquisitions.
General information
Firm type
Private Equity
Year founded
1993
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
Four Embarcadero Center, Suite 3720, San Francisco, CA 94111, United States
Sector focus
Frequently asked questions
What size investment does Montreux Growth Partners target?
The firm typically invests $10 to $20 million per company, directed at businesses with $5 to $50 million in annual revenue at the time of initial investment (per the firm website). That band places Montreux in the lower-middle-market growth segment, where it can serve as a lead or co-lead without requiring multi-hundred-million-dollar vehicles.
Which sectors does Montreux Growth Partners exclusively focus on?
Montreux invests solely in healthcare and financial technology companies, as stated on its own public materials. Within healthcare, recent disclosed activity clusters around practice-management software and clinical-communication platforms, but the firm has not published a list of specific subsector exclusions. The FinTech side of the portfolio is less transparent from publicly available information.
How does Montreux Growth Partners support portfolio companies beyond capital?
The firm emphasizes active post-investment support through a team that combines operational, financial, and sector expertise. Its involvement in the 2021 merger of Kareo and PatientPop to form Tebra suggests Montreux plays a hands-on role in strategic consolidation events, but the firm has not publicly detailed a formal operating-partner program or value-creation playbook.
Is Montreux Growth Partners open to outside co-investors or fund commitments?
Montreux operates as a single strategy, growth-equity investor with no publicly disclosed fund-of-funds structure, co-investment clubs, or vehicles designed for external LPs. Its disclosed posture suggests it deploys proprietary capital or raises discrete funds, but the exact funding structure — and whether it is a single- or multi-family pool — is not publicly confirmed.
Has Montreux Growth Partners made any recent exits or liquidity events?
In January 2022, portfolio company TigerConnect received a strategic growth investment from Vista Equity Partners, which likely provided partial or full liquidity to existing investors (per the firm, January 2022). Beyond that transaction and the Kareo-PatientPop merger that formed Tebra in November 2021, no other exit events are publicly disclosed on the firm's website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: